Lilly

Eli Lilly is a pharmaceutical company that develops and markets drugs, including its GLP-1 class medications for weight loss and diabetes.

Why it’s in the news: It is in the news for its soaring revenue and for taking legal action against pharmacies and vendors over the unauthorized sale of its upcoming weight-loss drug, retatrutide.

Latest on Lilly

• STAT+: Eli Lilly targets booming black market for retatrutide
• STAT+: Pharmalittle: We’re reading about Lilly ‘black market’ lawsuits, pushback over Trump vaccine plan, and more
• Eli Lilly is suing pharmacies and peptide vendors over sale of its next big weight-loss drug: retatrutide
• Lilly’s revenue soars 48%, driven by demand for its GLP-1s
• STAT+: Pharmalittle: We’re reading about a Lilly access program, a Gilead court victory, and more
• STAT+: Eli Lilly to allow more patients to apply for special access to unapproved obesity drug

Connections

8 entities linked to Lilly across the news graph.